← Back to Search

Leg Stretching Exoskeleton for Spasticity

N/A
Waitlist Available
Led By Steven W Brose
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 24 weeks
Awards & highlights

Study Summary

This trial is researching a device to help people with movement disorders improve leg & walking function, restore lost range of motion & gait, & improve quality of life.

Who is the study for?
This trial is for veterans with spasticity from a spinal cord injury that's at least 6 months old. They must be stable, able to consent, follow instructions, and not pregnant or recovering from recent surgeries. Participants should weigh under 300 lbs and not have other neurological disorders or conditions affecting mobility.Check my eligibility
What is being tested?
The study tests a wearable robotic exoskeleton designed to improve leg function and walking in people with movement issues due to neurological disorders. It involves exercises like leg stretching and treadmill walking to see how it affects muscle activity, joint motion, and gait.See study design
What are the potential side effects?
While the description doesn't specify side effects, potential ones may include discomfort while wearing the device, skin irritation where it attaches, muscle fatigue from use, or strain on joints during movement activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Perceived physical benefits
Secondary outcome measures
Follow-up sessions
Wearability and fit

Trial Design

1Treatment groups
Experimental Treatment
Group I: Robotic ExoskeletonExperimental Treatment1 Intervention
All participants will be interfered with a wearable robotic exoskeleton.

Find a Location

Who is running the clinical trial?

Syracuse UniversityOTHER
48 Previous Clinical Trials
117,564 Total Patients Enrolled
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,443 Total Patients Enrolled
1 Trials studying Movement Disorders
123 Patients Enrolled for Movement Disorders
Steven W BrosePrincipal InvestigatorSyracuse VA Medical Center, Syracuse, NY

Media Library

Robotic Exoskeleton Clinical Trial Eligibility Overview. Trial Name: NCT05926596 — N/A
Movement Disorders Research Study Groups: Robotic Exoskeleton
Movement Disorders Clinical Trial 2023: Robotic Exoskeleton Highlights & Side Effects. Trial Name: NCT05926596 — N/A
Robotic Exoskeleton 2023 Treatment Timeline for Medical Study. Trial Name: NCT05926596 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any slots still available to join the research project?

"Unfortunately, as reported on the clinicaltrials.gov portal, this medical trial is no longer accepting new patients. The original postdate was October 1st 2023 and it has not been modified since June 22nd of the same year. Fortunately, there are still 454 other active trials recruiting participants at present."

Answered by AI
~5 spots leftby Sep 2024